Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention

par Kisalu, Neville K., Pereira, Lais D., Ernste, Keenan, Flores-Garcia, Yevel, Idris, Azza H., Asokan, Mangaiarkarasi, Dillon, Marlon, MacDonald, Scott, Shi, Wei, Chen, Xuejun, Pegu, Amarendra, Schön, Arne, Zavala, Fidel, Balazs, Alejandro B., Francica, Joseph R., Seder, Robert A.
Publié dans JCI Insight (2021)

Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody

par Asokan, Mangaiarkarasi, Dias, Joana, Liu, Cuiping, Maximova, Anna, Ernste, Keenan, Pegu, Amarendra, McKee, Krisha, Shi, Wei, Chen, Xuejun, Almasri, Cassandra, Promsote, Wanwisa, Ambrozak, David R., Gama, Lucio, Hu, Jianfei, Douek, Daniel C., Todd, John-Paul, Lifson, Jeffrey D., Fourati, Slim, Sekaly, Rafick P., Crowley, Andrew R., Ackerman, Margaret E., Ko, Sung Hee, Kilam, Divya, Boritz, Eli A., Liao, Laura E., Best, Katharine, Perelson, Alan S., Mascola, John R., Koup, Richard A.
Publié dans Proc Natl Acad Sci U S A (2020)